ProMIS Neurosciences Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ProMIS Neurosciences Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($11.58M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($10.12M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($7.35M) | May 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $9.28M | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($2.62M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($3.64M) | May 12, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.36M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($2.31M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($4.96M) | May 14, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($5.96M) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($2.75M) | Aug 14, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($2.09M) | May 15, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($1.21M) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($225.5K) | Aug 12, 2022 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($11.75M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($10.18M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($7.46M) | May 12, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($4.43M) | Nov 12, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($2.71M) | Aug 13, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($3.68M) | May 12, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.52M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($2.90M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($4.97M) | May 14, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($6.05M) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($4.86M) | Aug 14, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($3.94M) | May 15, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($2.07M) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($1.11M) | Aug 12, 2022 |